Immune system support during flu season
Pro Research Analysisby 
Searched over 200M research papers
T Cell Immunity and Cross-Protection During Flu Season
T cells play a crucial role in protecting the body against both seasonal and pandemic influenza. People with higher levels of influenza-specific T cells, especially those targeting conserved internal proteins, are less likely to develop symptoms even if they become infected. This protection is independent of antibody levels and helps explain why many flu infections are asymptomatic. Stimulating T cell responses, either naturally or through vaccines, can provide broad, cross-protective immunity against different flu strains, making T cell-focused strategies important for immune support during flu season Hayward2015Nakaya2015.
B Cell and Antibody Responses for Flu Defense
B cells are essential for producing antibodies that neutralize the influenza virus. The B cell response is highly adaptable, involving both early and late phases of protection and different types of B cells. This flexibility allows the immune system to respond to the constantly changing influenza virus, reducing illness severity and death even when complete immunity is not achieved quickly . Vaccines that enhance B cell and antibody responses, especially those that increase IgG and IgA levels, can help the body mount a stronger defense against the flu Lewis2022Schmidt2021.
Dietary Supplements and Immune Function Enhancement
Certain dietary supplements have been shown to support immune function during flu season. For example, supplementation with UP360 or UP446 increased specific immune cell populations and antibody levels after flu vaccination, suggesting a more robust immune response. These supplements also increased antioxidant enzyme levels, which may help reduce oxidative stress related to infection or vaccination. However, while immune markers improved, there was no significant difference in the frequency or severity of flu-like symptoms among participants .
Aged garlic extract (AGE) is another supplement that can enhance immune cell function, particularly γδ-T and natural killer (NK) cells. Regular consumption of AGE led to better proliferation and activation of these cells and was associated with reduced severity of cold and flu symptoms, fewer days of suboptimal functioning, and fewer missed work or school days .
Vaccine Strategies and Adjuvants for Broader Protection
Current flu vaccines mainly induce strain-specific antibodies, which may not protect against new or drifted strains. New strategies focus on stimulating broader immune responses, including T cell and B cell immunity. For example, adding virus-like particles containing multiple influenza proteins to vaccines has improved protection in older adults, increasing both antibody and T cell responses and providing better defense against various flu strains .
Adjuvants that activate multiple immune pathways, such as toll-like receptor (TLR) agonists, can also enhance vaccine effectiveness. These adjuvants promote strong humoral and cell-mediated immunity, leading to better protection against different influenza subtypes . Live attenuated vaccines like FluMist have been shown to induce cross-reactive T cell immunity, reducing both flu severity and the risk of secondary bacterial infections .
Shared Immune Signatures and Population-Level Insights
Research shows that certain immune signatures, such as innate immune activation and plasmablast responses, are consistently linked to strong antibody production after flu vaccination across different populations and seasons. These shared patterns can help guide the development of next-generation vaccines that provide longer-lasting and broader protection .
Conclusion
Supporting the immune system during flu season involves a combination of strategies: enhancing T cell and B cell responses, considering dietary supplements like aged garlic extract, and using advanced vaccine formulations and adjuvants. These approaches can help reduce the risk and severity of influenza, especially in vulnerable populations, and contribute to better overall immune defense during flu season Hayward2015Lewis2022Lam2019+6 MORE.
Sources and full results
Most relevant research papers on this topic
Natural T Cell-mediated Protection against Seasonal and Pandemic Influenza. Results of the Flu Watch Cohort Study.
Natural T-cell immunity protects against symptomatic PCR-confirmed influenza in those with evidence of infection, explaining why many infections do not cause symptoms.
The Multifaceted B Cell Response to Influenza Virus
The influenza-specific B cell response is multifaceted, involving both innate-like and conventional B cells, providing early and later immune protection, and continuously adapting to the ever-changing virus while enhancing overall protection.
Influenza vaccines using liposomal formulations of toll-like receptor (TLR) 7/8 and 4 agonists as adjuvants
The TRAC-478 adjuvant system, combining synthetic TLR7/8 and TLR4 agonists, can enhance influenza vaccine immunity and provide more robust protection against various subtypes of influenza virus.
T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine
T cell-based flu immunity, particularly tissue-resident memory T cells in the respiratory tract, shows promise for a universal flu vaccine that provides broad immunity against conserved influenza strains.
Early Bird Gets the Flu: What Should Be Done About Waning Intraseasonal Immunity Against Seasonal Influenza?
A nuanced approach to seasonal vaccine programs, considering duration of immunity as well as coverage, is needed to address waning intraseasonal immunity among vaccinated individuals.
DOI